Cinta Mancheño‐Velasco
Biographic Data
| ID | 7521768 |
|---|---|
| NAME | Cinta Mancheño‐Velasco |
| GIVEN NAMES | Cinta |
| FAMILY NAME | Mancheño‐Velasco |
| SIGNATURE | VELASCO C M |
| AFFILIATIONS | Universidad de Huelva |
| ORCID | 0009-0006-3783-4166 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Coordinated Treatment for Dual Diagnosis
Objective This study aims to compare the process and outcome indicators of treatment between patients with dual diagnosis (DD) receiving coordinated care and those diagnosed with only substance use disorders (SUD) treated in addiction centers. It also aims to identify the impact of impact psychiatric comorbidity has on indicators of the therapeutic process and outcomes.Methods Data were extracted from the electronic health records (HER) of 93,566…
Mortality and Readmission in Opioid Patients
Aim Analyze risk factors for treatment readmission and mortality among patients with opioid use disorder (OUD). Methods A retrospective, multicenter study analyzed a cohort of 16,343 patients treated at 124 public outpatient treatment centers for substance use disorders in Spain, by using a recurrent-event survival analysis with terminal events. Results Factors increasing the likelihood of treatment readmission included having a child, opioid use…
Readmission and Dropout in Outpatient Centers
Substance use disorder treatment faces challenges such as dropout, relapse, and readmission. This study aims to identify factors associated with readmission and those influencing dropout among dual diagnosis (DD) patients (those with both a substance use disorder and another psychiatric disorder) attending outpatient addiction centers. Retrospective cohort study using the electronic health records of 8383 outpatients diagnosed with DD. Bivariate …
No prominent works on this page.
Readmission and Dropout in Outpatient Centers
Substance use disorder treatment faces challenges such as dropout, relapse, and readmission. This study aims to identify factors associated with readmission and those influencing dropout among dual diagnosis (DD) patients (those with both a substance use disorder and another psychiatric disorder) attending outpatient addiction centers. Retrospective cohort study using the electronic health records of 8383 outpatients diagnosed with DD. Bivariate …
Coordinated Treatment for Dual Diagnosis
Objective This study aims to compare the process and outcome indicators of treatment between patients with dual diagnosis (DD) receiving coordinated care and those diagnosed with only substance use disorders (SUD) treated in addiction centers. It also aims to identify the impact of impact psychiatric comorbidity has on indicators of the therapeutic process and outcomes.Methods Data were extracted from the electronic health records (HER) of 93,566…
Mortality and Readmission in Opioid Patients
Aim Analyze risk factors for treatment readmission and mortality among patients with opioid use disorder (OUD). Methods A retrospective, multicenter study analyzed a cohort of 16,343 patients treated at 124 public outpatient treatment centers for substance use disorders in Spain, by using a recurrent-event survival analysis with terminal events. Results Factors increasing the likelihood of treatment readmission included having a child, opioid use…
Opioid Use Disorder Treatment (3 works) · Substance Abuse Treatment and Outcomes (3 works) · Addiction (2 works) · Comorbidity (2 works) · Dual diagnosis (2 works) · Health psychology (2 works) · Medicine (2 works) · Psychiatry (2 works) · Public health (2 works) · Schizophrenia research and treatment (2 works)